Perceptive
Private Company
Funding information not available
Overview
Perceptive is a specialized service provider in the clinical research ecosystem, offering critical imaging and eClinical solutions. Founded in 2016 and headquartered in London, the company has established itself as a trusted partner by supporting over 11,000 trials and 3,000 preclinical studies. Its core business integrates deep scientific expertise in imaging modalities with robust IRT/RTSM technology to de-risk and streamline clinical development for biopharma sponsors and CROs. The company operates globally, providing end-to-end support from protocol design through regulatory submission.
Technology Platform
Integrated service platform combining Imaging Core Lab capabilities (with VivoQuant™ analysis software), Preclinical Imaging, and IRT/RTSM (Interactive Response Technology) systems for clinical trial randomization and supply management.
Opportunities
Risk Factors
Competitive Landscape
Perceptive competes in two crowded segments: imaging core lab services (against players like BioClinica, ICON plc, and Clario) and IRT/RTSM services (against providers like YPrime, endpoint Clinical, and solutions from large CROs). Its differentiation is based on deep scientific expertise, a combined service offering, and a strong track record, but it must continually innovate to compete with larger players' scale and resources.